Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases.
Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged Care Facilities (RACF) and of current residents to ensure they are up to date with all recommended vaccinations including Pneumococcal, COVID-19, Influenza and Zoster.
If you need assistance in how to access AIR immunisation history statements via practice management software please contact us.
Shield yourself from shingles
The new “Shield yourself from shingles” resource collection contains factsheets, brochures, and posters about shingles vaccinations for eligible people.
Recordings of the NCIRS webinar ‘New shingles vaccine on the NIP’ are now available.
A knowledgeable panel of domestic and international experts presented and answered questions on topics including the disease burden of shingles in Australia, details about Shingrix®, including clinical trial results and mechanism of protection, and the new Australian shingles program, including eligibility for NIP-funded vaccination.
How many doses of a shingles vaccine are required?
Should a person receive a shingles vaccine if they have had a chickenpox (varicella) vaccine?
Can a person receive other vaccines at the same time as shingles vaccines?
If a person has already received a dose of Zostavax®, can they receive Shingrix®?
The resource includes the latest information about Shingrix® (and its predecessor on the NIP, Zostavax®), and gives a detailed description of NIP eligibility as well as an overview of shingles disease.
AusVaxSafety commences Shingrix® surveillance
AusVaxSafety is conducting enhanced active surveillance of Shingrix® across Australia to provide reassurance that the short-term safety profile of the vaccine is consistent with previous data.
Shingrix® vaccine safety data will be published on the AusVaxSafety website and updated monthly once enough data are collected to allow meaningful analysis.
COVID-19 Vaccine Administration Error (VAE) reporting form
Vaccine providers can now report a COVID-19 vaccine administration error using the new VAE reporting form.
Pertussis (whooping cough)
NSW Health have cautioned GPs that whooping cough infection is starting to increase in NSW and GPs should order a PCR test for people with clinical features of pertussis, even if fully vaccinated. If pertussis is suspected, ask the patient to avoid contact with babies and pregnant women while the result is pending.
pregnant women, who should be vaccinated between 20-32 weeks gestation (ideally at 28 weeks) to provide antibodies to their infant for protection in the first few months of life infants and their siblings
adults who care for infants (aged under 6 months) who have not received a booster in the last 10 years
HealthPathways provides health professionals in CESPHN with access to up-to-date clinical information and resources to support assessment, management, and referral of their patients. For more information visit the Pertussis (Whooping Cough) pathway:
Workshop: Overseas Encounters and Catch Ups REGISTER
This webinar will workshop two scenarios of translating overseas vaccination records and developing catch-up schedules. Catch up planning will include both paper-based method and online calculator method. Date: Thursday 30 November Time: 8.00pm – 9.00pm
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…